Increased expression of BUB1 is associated with resistance to DNA-damaging agents (i.e. radiotherapy and some chemotherapies) [12] and we have shown that BUB1 inhibition reduces invasion and migration in cancer cell lines [13] through direct interaction with TGFβ receptors [14, 15]. This evidence concerns the gene BUB1 and cancer.